We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The broad scope of the pharmaceutical manufacturing landscape is making merger and acquisition activity in the sector ever more complex with several varying factors driving decisions, according to a recent CPhI Webinar sponsored by PharmaVentures.